U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), a fatal ...
A research team in Japan has developed an innovative system that can accurately detect genetic mutations in brain tumors within just 25 minutes. Genetic mutations are crucial markers for diagnosis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback